NZ257212A
(en)
*
|
1992-09-29 |
1996-11-26 |
Inhale Therapeutic Syst |
Parathyroid hormone formulations comprising a biologically active n-terminal fragment of the hormone
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
JPH10508744A
(ja)
|
1994-09-22 |
1998-09-02 |
クオドラント ホールディングス ケンブリッジ リミテッド |
運動競技の間の水分補給および栄養摂取の用途のための組成物ならびにその製造法
|
US6964771B1
(en)
*
|
1995-06-07 |
2005-11-15 |
Elan Drug Delivery Limited |
Method for stably incorporating substances within dry, foamed glass matrices
|
US6509146B1
(en)
|
1996-05-29 |
2003-01-21 |
Universal Preservation Technologies, Inc. |
Scalable long-term shelf preservation of sensitive biological solutions and suspensions
|
US6468782B1
(en)
*
|
1996-12-05 |
2002-10-22 |
Quadrant Healthcare (Uk) Limited |
Methods of preserving prokaryotic cells and compositions obtained thereby
|
GB9705588D0
(en)
|
1997-03-18 |
1997-05-07 |
Anglia Research Foundation |
Stable particle in liquid formulations
|
US20060116330A1
(en)
*
|
1997-07-08 |
2006-06-01 |
The Iams Company |
Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
|
US8563522B2
(en)
*
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
US20020035071A1
(en)
*
|
1997-07-08 |
2002-03-21 |
Josef Pitha |
Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
DE69735600T2
(de)
*
|
1997-11-26 |
2007-01-25 |
Universal Preservation Technologies, Inc., San Diego |
Konservierung empfindlicher biologischer proben durch verglasung
|
US6306345B1
(en)
*
|
1998-05-06 |
2001-10-23 |
Universal Preservation Technologies, Inc. |
Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures
|
US6214054B1
(en)
|
1998-09-21 |
2001-04-10 |
Edwards Lifesciences Corporation |
Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
|
CA2360112A1
(en)
|
1999-01-05 |
2000-07-13 |
Victor Bronshtein |
Vacuum control system for foam drying apparatus
|
DK1175486T3
(da)
*
|
1999-05-04 |
2007-10-29 |
Anhydro Ltd |
Fremgangsmåde til konservering af virus og mycoplasma
|
US6692695B1
(en)
|
1999-05-06 |
2004-02-17 |
Quadrant Drug Delivery Limited |
Industrial scale barrier technology for preservation of sensitive biological materials
|
CA2382061A1
(en)
*
|
1999-08-19 |
2001-02-22 |
Victor Bronshtein |
Preservation of bacterial cells at ambient temperatures
|
WO2001037804A2
(en)
*
|
1999-11-22 |
2001-05-31 |
Universal Preservation Technologies, Inc. |
Preservation and formulation of bioactive materials
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
DK1280520T4
(en)
|
2000-05-10 |
2018-06-25 |
Novartis Ag |
Phospholipid based powders for drug delivery
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
WO2001094867A1
(en)
|
2000-06-07 |
2001-12-13 |
Universal Preservation Technologies, Inc. |
Industrial scale barrier technology for preservation of sensitive biological materials
|
HU229550B1
(en)
*
|
2000-06-27 |
2014-01-28 |
Hoffmann La Roche |
Method for preparing compositions
|
US6537666B1
(en)
*
|
2000-10-23 |
2003-03-25 |
Universal Preservation Technologies, Inc. |
Methods of forming a humidity barrier for the ambient temperature preservation of sensitive biologicals
|
US6872357B1
(en)
*
|
2000-11-22 |
2005-03-29 |
Quadrant Drug Delivery Limited |
Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying
|
US7153472B1
(en)
*
|
2000-11-22 |
2006-12-26 |
Quadrant Drug Delivery Limited |
Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
|
AU2002305461A1
(en)
*
|
2001-05-07 |
2002-11-18 |
Universal Preservation Technologies, Inc. |
Preservation of competent cells at ambient temperatures
|
US6884866B2
(en)
*
|
2001-10-19 |
2005-04-26 |
Avant Immunotherapeutics, Inc. |
Bulk drying and the effects of inducing bubble nucleation
|
EP1458360B1
(en)
|
2001-12-19 |
2011-05-11 |
Novartis AG |
Pulmonary delivery of aminoglycosides
|
US6878168B2
(en)
|
2002-01-03 |
2005-04-12 |
Edwards Lifesciences Corporation |
Treatment of bioprosthetic tissues to mitigate post implantation calcification
|
CA2482448C
(en)
*
|
2002-04-11 |
2014-07-08 |
Medimmune Vaccines, Inc. |
Preservation of bioactive materials by freeze dried foam
|
US7927858B2
(en)
|
2002-11-01 |
2011-04-19 |
Glaxosmithkline Biologicals, S.A. |
Drying process
|
US20050100559A1
(en)
*
|
2003-11-07 |
2005-05-12 |
The Procter & Gamble Company |
Stabilized compositions comprising a probiotic
|
US20050100636A1
(en)
*
|
2003-11-10 |
2005-05-12 |
Megan Botteri |
[A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity]
|
US8894991B2
(en)
*
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
US8877178B2
(en)
*
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
US20050152884A1
(en)
*
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
US20050158294A1
(en)
*
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
US9744227B2
(en)
|
2004-06-02 |
2017-08-29 |
Universal Stabilization Technologies, Inc. |
Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof
|
CA2569276C
(en)
|
2004-06-02 |
2018-01-23 |
Victor Bronshtein |
Preservation by vaporization
|
JP2007277094A
(ja)
*
|
2004-06-29 |
2007-10-25 |
Chemo Sero Therapeut Res Inst |
改変ダニ主要アレルゲン含有医薬組成物
|
CA2571232C
(en)
*
|
2004-07-30 |
2010-02-16 |
The University Of British Columbia |
Method for producing hydrocolloid foams
|
AR052472A1
(es)
*
|
2005-05-31 |
2007-03-21 |
Iams Company |
Lactobacilos probioticos para felinos
|
EP1885383B1
(en)
*
|
2005-05-31 |
2016-09-21 |
IAMS Europe B.V. |
Feline probiotic bifidobacteria
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
WO2007079147A2
(en)
|
2005-12-28 |
2007-07-12 |
Advanced Bionutrition Corporation |
A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
US9453675B2
(en)
*
|
2006-02-10 |
2016-09-27 |
Sp Industries, Inc. |
Method of inducing nucleation of a material
|
EP2077718B2
(en)
|
2006-10-27 |
2022-03-09 |
Edwards Lifesciences Corporation |
Biological tissue for surgical implantation
|
CA2673120C
(en)
|
2006-12-18 |
2012-08-07 |
Advanced Bionutrition Corporation |
A dry food product containing live probiotic
|
WO2008093303A2
(en)
|
2007-02-01 |
2008-08-07 |
The Iams Company |
Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
|
US8617576B2
(en)
*
|
2007-05-18 |
2013-12-31 |
Medimmune, Llc |
Preservation of bioactive materials by freeze dried foam
|
US9101691B2
(en)
*
|
2007-06-11 |
2015-08-11 |
Edwards Lifesciences Corporation |
Methods for pre-stressing and capping bioprosthetic tissue
|
JP2010534622A
(ja)
|
2007-07-26 |
2010-11-11 |
サノフィ パストゥール リミテッド |
抗原−アジュバント組成物および方法
|
CA2699120C
(en)
*
|
2007-09-13 |
2014-07-08 |
Enwave Corporation |
Apparatus and method for dehydrating biological materials
|
US8357387B2
(en)
*
|
2007-12-21 |
2013-01-22 |
Edwards Lifesciences Corporation |
Capping bioprosthetic tissue to reduce calcification
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
CA2736317C
(en)
|
2008-09-12 |
2015-06-16 |
Enwave Corporation |
Apparatus and method for dehydrating biological materials with freezing and microwaving
|
EP3266448B1
(en)
|
2009-03-27 |
2022-02-16 |
Intervet International B.V. |
Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
|
CN102459568A
(zh)
|
2009-05-26 |
2012-05-16 |
先进生物营养公司 |
包含生物活性微生物和/或生物活性材料的稳定干粉组合物及其制造方法
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
US20110064723A1
(en)
*
|
2009-09-14 |
2011-03-17 |
Aridis Pharmaceuticals |
Formulation for room temperature stabilization of a live attenuated bacterial vaccine
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
SG182317A1
(en)
|
2010-01-28 |
2012-08-30 |
Advanced Bionutrition Corp |
Dry glassy composition comprising a bioactive material
|
EP2549957B1
(en)
|
2010-03-23 |
2019-01-30 |
Edwards Lifesciences Corporation |
Methods of conditioning sheet bioprosthetic tissue
|
US8906601B2
(en)
|
2010-06-17 |
2014-12-09 |
Edwardss Lifesciences Corporation |
Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
|
RS57588B1
(sr)
*
|
2010-08-13 |
2018-11-30 |
Advanced Bionutrition Corp |
Supstanca za stabilizaciju bioloških materijala za suvo skladištenje
|
US9351829B2
(en)
|
2010-11-17 |
2016-05-31 |
Edwards Lifesciences Corporation |
Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
|
US10238771B2
(en)
|
2012-11-08 |
2019-03-26 |
Edwards Lifesciences Corporation |
Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
|
PT3003246T
(pt)
|
2013-05-31 |
2021-02-22 |
Victor Bronshtein |
Composições poliméricas contendo produtos biofarmacêuticos estáveis à temperatura ambiente e métodos para a formulação dos mesmos
|
US9615922B2
(en)
|
2013-09-30 |
2017-04-11 |
Edwards Lifesciences Corporation |
Method and apparatus for preparing a contoured biological tissue
|
US10959839B2
(en)
|
2013-10-08 |
2021-03-30 |
Edwards Lifesciences Corporation |
Method for directing cellular migration patterns on a biological tissue
|
US9938558B2
(en)
|
2015-06-25 |
2018-04-10 |
Ascus Biosciences, Inc. |
Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
|
EP3314007B1
(en)
|
2015-06-25 |
2024-01-24 |
Native Microbials, Inc. |
Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
|
US10851399B2
(en)
|
2015-06-25 |
2020-12-01 |
Native Microbials, Inc. |
Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
|
WO2018126026A1
(en)
|
2016-12-28 |
2018-07-05 |
Ascus Biosciences, Inc. |
Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
|
AU2016297986B8
(en)
|
2015-07-29 |
2020-06-11 |
Advanced Bionutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
RU2018140070A
(ru)
|
2016-04-15 |
2020-05-15 |
Аскус Байосайенсиз, Инк. |
Способы улучшения сельскохозяйственного производства птицы путем применения микробных консорциумов или их штаммов
|
CN106434840B
(zh)
*
|
2016-12-02 |
2019-08-09 |
北京中检葆泰生物技术有限公司 |
一种用于微生物法定量检测维生素b12的微孔板、其试剂盒及其制备方法
|
CN110352250A
(zh)
|
2016-12-28 |
2019-10-18 |
埃斯库斯生物科技股份公司 |
用于通过示踪剂分析法对复杂异质群落进行微生物株系分析、确定其功能关系及相互作用以及合成包括给药微生物群集和接种微生物群集的微生物群集的方法、设备和系统
|
CN106676161B
(zh)
*
|
2017-01-03 |
2020-01-21 |
北京中检葆泰生物技术有限公司 |
一种用于微生物法定量检测烟酸的微孔板、其试剂盒及其制备方法
|
CN106676160B
(zh)
*
|
2017-01-03 |
2020-02-21 |
北京中检葆泰生物技术有限公司 |
一种用于微生物法定量检测泛酸的微孔板、其试剂盒及其制备方法
|
CN106591415B
(zh)
*
|
2017-01-03 |
2019-12-10 |
北京中检葆泰生物技术有限公司 |
一种用于微生物法定量检测生物素的微孔板、其试剂盒及其制备方法
|
CN106701887B
(zh)
*
|
2017-01-03 |
2020-01-17 |
北京中检葆泰生物技术有限公司 |
一种用于微生物法定量检测叶酸的微孔板、其试剂盒及其制备方法
|
US10617756B2
(en)
|
2017-01-05 |
2020-04-14 |
Shimojani, LLC |
Drug regimen for treatment of cerebral ischemia
|
WO2018201154A1
(en)
*
|
2017-04-28 |
2018-11-01 |
Universal Stabilization Technologies, Inc. |
Antigenic thermostable polio vaccines & related methods
|
CA3062547A1
(en)
|
2017-05-31 |
2018-12-06 |
Edwards Lifesciences Corporation |
Collagen fibers and articles formed therefrom
|
CN111970933A
(zh)
|
2017-10-18 |
2020-11-20 |
埃斯库斯生物科技股份公司 |
通过施用微生物或其纯化菌株的合成生物集合体来提高禽类产量
|
CN111491675A
(zh)
|
2018-01-23 |
2020-08-04 |
爱德华兹生命科学公司 |
用于预拉伸可植入生物相容性材料的方法及其生产的材料和装置
|
JP7138336B2
(ja)
*
|
2018-06-29 |
2022-09-16 |
国立大学法人九州工業大学 |
生体由来の水溶性高分子乾燥品の製造方法及びその製造装置
|
CA3116158A1
(en)
|
2018-11-01 |
2020-05-07 |
Edwards Lifesciences Corporation |
Transcatheter pulmonic regenerative valve
|